CAPTRUST Financial Advisors’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.05K Buy
+11,469
New +$10.7K ﹤0.01% 2999
2023
Q3
Sell
-208,448
Closed -$957K 2683
2023
Q2
$957K Sell
208,448
-10,808
-5% -$49.7K ﹤0.01% 1233
2023
Q1
$1.09M Buy
219,256
+38,447
+21% +$189K ﹤0.01% 993
2022
Q4
$987K Buy
180,809
+80,555
+80% +$494K 0.01% 979
2022
Q3
$652K Buy
100,254
+100,203
+196,476% +$559K ﹤0.01% 1122
2022
Q2
$0 Buy
51
+14
+38% +$69 ﹤0.01% 5060
2022
Q1
$0 Buy
+37
New +$253 ﹤0.01% 5052
2021
Q4
Sell
-171
Closed -$2K 4857
2021
Q3
$2K Buy
+171
New +$2.58K ﹤0.01% 4281

Other funds holding MXCT

CAPTRUST Financial Advisors's MXCT Position: Q1 2026 in Review

CAPTRUST Financial Advisors opened a new position in MaxCyte (MXCT) in Q1 2026: 11,469 shares worth $8.05K. The stake represents ﹤0.01% of the portfolio and ranks #2999 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in MXCT as recently as Q2 2023.

CAPTRUST Financial Advisors first reported a position in MXCT in Q3 2021 and has held it in 8 quarters since. The position peaked at $1.09M in Q1 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • CAPTRUST Financial Advisors held 11,469 shares of MaxCyte worth $8.05K as of Q1 2026.
  • MaxCyte was a new CAPTRUST Financial Advisors position in Q1 2026.
  • MaxCyte made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2999 holding.
  • CAPTRUST Financial Advisors first reported a position in MaxCyte in Q3 2021 and has held it in 8 quarters since.
  • CAPTRUST Financial Advisors's MaxCyte position peaked at $1.09M in Q1 2023.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.